Smoltek Q2 FY26 loss widens to SEK 10.92 million; net sales show no revenue

• Smoltek posted a Q2 2026 consolidated loss of SEK 10.92 million, widening from SEK 10.01 million a year earlier.
• Net sales were unchanged at no net sales, versus SEK 44,000 a year earlier.
• Loss per share improved to SEK -0.06 from SEK -0.12, while the equity ratio slipped 1.5 percentage points to 70.9%.
• Cash and cash equivalents fell to SEK 1.86 million from SEK 4.72 million; equity rose to SEK 126.34 million from SEK 85.87 million.
• Management highlighted a heavily oversubscribed rights issue raising about SEK 82 million, alongside intensified customer work in Taiwan and a planned 3,000-hour durability test with Heraeus.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Smoltek Nanotech Holding AB published the original content used to generate this news brief via Cision (Ref. ID: 20260825:BIT:1730:0) on August 26, 2026, and is solely responsible for the information contained therein.